Is now the right time to consider listing?

Perspectives on growth, funding and public markets for life sciences businesses

Freeths and London Stock Exchange Group are pleased to invite you to an exclusive roundtable discussion exploring whether now is the right time for life sciences businesses to consider listing, and how management teams should be approaching growth, funding and value creation in the current market.

Against a backdrop of evolving government policy, shifting investor sentiment and ongoing funding pressures, many life sciences businesses are reassessing their options for securing capital and supporting their next phase of growth. Whilst public markets may not be right for every business, there is renewed discussion around the role capital markets can play alongside venture, private equity and other funding routes.

What to expect

This invitation-only session will bring together a select group of life sciences founders, CFOs, CEOs, COOs, investors and advisers for a candid discussion on:

• Whether public markets are becoming a viable route for growth in the life sciences sector

• The current funding environment and what investors are looking for

• Alternative pathways to raise capital and unlock growth

• Governance, timing and readiness considerations for scaling businesses

• How founders can prepare for future funding, liquidity and exit opportunities

The discussion will feature insights from:

• Tim Davis, Regional Head (Primary Markets), London Stock Exchange Group

• Jeremy Swift, Corporate Partner, Freeths

• Additional guest contributors to be confirmed

The session will be held under the Chatham House Rule to encourage open and honest discussion amongst attendees.

Breakfast and networking will be available from 9.00am, with the roundtable commencing at 9.30am.

Places are limited to ensure a focused and interactive discussion.

We hope you can join us.